FDA Clearance Tracker · P060025-S009
ATS 3F AORTIC BIOPROSTHESIS
Last checked: Nov 20, 2026Latest source record: Oct 26, 2012 (this decision)Source: openFDAMethods & limitations
Decided
Oct 26, 2012
Approved
Time to decision
179 days
Received Apr 30, 2012. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P060025-S009
- Device name
- ATS 3F AORTIC BIOPROSTHESIS
- Applicant
- Medtronic, Inc.
- Applicant location
- Minneapolis, MN
- Received
- Apr 30, 2012
- Decided
- Oct 26, 2012
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P060025
Device type
- Device type
- heart-valve, non-allograft tissue (LWR)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
K262913 · Decided Sep 17, 2026 · 29 days after receipt
Device type: Stents, Drains And Dilators For The Biliary Ducts (FGE) · GI, Urology & Nephrology
K262735 · Decided Aug 28, 2026 · 28 days after receipt
Device type: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.